BRIEF published on 05/20/2025 at 19:38, 1 year 2 months ago Recording of Nebius Group Q1 2025 Earnings Call Available Financial Performance Investor Relations Earnings Call Nebius Group Q1 2025
BRIEF published on 05/20/2025 at 19:38, 1 year 2 months ago Enregistrement de la conférence téléphonique sur les résultats du premier trimestre 2025 du groupe Nebius disponible Performance Financière Relations Avec Les Investisseurs Conférence Téléphonique Sur Les Résultats Groupe Nébius T1 2025
PRESS RELEASE published on 05/20/2025 at 19:33, 1 year 2 months ago Q1 Earnings Call – Recording now available Nebius Group releases Q1 2025 earnings call recording. Available on investor relations website. Contacts: media@nebius.com, askIR@nebius.com Investor Relations Financials Earnings Call Nebius Group Q1 2025
BRIEF published on 05/20/2025 at 13:20, 1 year 2 months ago Nebius Group N.V. Reports Substantial Revenue Growth in Q1 2025 Revenue Growth Adjusted EBITDA Loss AI Infrastructure Subsidiaries Toloka Investment
BRIEF published on 05/20/2025 at 13:20, 1 year 2 months ago Nebius Group NV annonce une croissance substantielle de son chiffre d'affaires au premier trimestre 2025 Croissance Des Revenus Filiales Infrastructure D'IA Toloka Investment Perte D'EBITDA Ajusté
PRESS RELEASE published on 05/20/2025 at 13:15, 1 year 2 months ago Nebius Group N.V. announces first quarter 2025 financial results Nebius Group N.V. announced its unaudited financial results for Q1 2025, with a revenue increase of 385% driven by AI infrastructure. Webcast on May 20, 2025. For more details, visit group.nebius.com/investor-hub Financial Results Webcast AI Infrastructure Q1 2025 Nebius Group N.V.
BRIEF published on 05/07/2025 at 13:06, 1 year 3 months ago Nebius Welcomes Bezos Expeditions as Lead Investor in Toloka Nebius Group AI Investment Bezos Expeditions Toloka Expansion AI Data Business
BRIEF published on 05/07/2025 at 13:06, 1 year 3 months ago Nebius accueille Bezos Expeditions comme investisseur principal à Toloka Groupe Nébius Investissement Dans L'IA Expéditions Bezos Extension De Toloka IA, Données Commerciales
PRESS RELEASE published on 05/07/2025 at 13:01, 1 year 3 months ago Nebius welcomes Bezos Expeditions as lead investor in AI data business Toloka Nebius Group welcomes Bezos Expeditions as lead investor in AI data business Toloka, positioning Toloka among top tier of AI data companies globally Investment Nebius Group Bezos Expeditions AI Data Business Toloka
BRIEF published on 04/30/2025 at 14:06, 1 year 3 months ago Nebius Group N.V. to Announce Q1 2025 Results and Host Conference Call Conference Call AI Infrastructure Nebius Group Q1 2025 Results NASDAQ: NBIS
Published on 08/10/2026 at 08:00, 2 hours 9 minutes ago Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 2 hours 9 minutes ago Results of AGM and Management Update Presentation
Published on 08/07/2026 at 23:15, 2 days 10 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 11 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/10/2026 at 09:50, 19 minutes ago Photon Energy N.V. Bond 21/27 (ISIN: DE000A3KWKY4): Signs of a crisis are mounting. What can investors do? Invitation to video conferences (German/English)
Published on 08/10/2026 at 09:00, 1 hour 9 minutes ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 9 minutes ago Original-Research: Bittium Oyj (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 9 minutes ago Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients
Published on 08/10/2026 at 09:22, 47 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 09:22, 47 minutes ago Nombre total d'actions et droits de vote - juillet 2026
Published on 08/10/2026 at 07:00, 3 hours 9 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 3 hours 9 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
